APA (7th ed.) Citation

JD, P., AT, F., JC, K., LN, S., O, F., RD, M., . . . CR, L. (2023). Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use. Addiction science & clinical practice, 18(1), 51. https://doi.org/10.1186/s13722-023-00408-8

Chicago Style (17th ed.) Citation

JD, Pytell, Fojo AT, Keruly JC, Snow LN, Falade-Nwulia O, Moore RD, Chander G, and Lesko CR. "Measuring Time in Buprenorphine Treatment Stages Among People with HIV and Opioid Use Disorder by Retention Definition and Its Association with Cocaine and Hazardous Alcohol Use." Addiction Science & Clinical Practice 18, no. 1 (2023): 51. https://doi.org/10.1186/s13722-023-00408-8.

MLA (9th ed.) Citation

JD, Pytell, et al. "Measuring Time in Buprenorphine Treatment Stages Among People with HIV and Opioid Use Disorder by Retention Definition and Its Association with Cocaine and Hazardous Alcohol Use." Addiction Science & Clinical Practice, vol. 18, no. 1, 2023, p. 51, https://doi.org/10.1186/s13722-023-00408-8.